Our Company   |   Executive Leadership Team

DAVA Oncology, LP …a new perspective in clinical research


Our Mission

To improve patient care by realizing the full potential of oncology drug development.

Our Business

Since its inception in April 2007, DAVA Oncology has been dedicated to the improvement of patient care by redefining clinical research.

Located in Dallas our growing team of oncology professionals, supported by expert advisors, provides strategic & operational services to advance drug development and accelerate clinical trials.

Our Services

Strategic Consulting:

1. Strategic Intelligence
2. Congress Coverage
3. Clinical Development Planning
4. Competitive Landscape Analysis

 

Research Consortia:

1. Breast Cancer Research Consortium
2. Lymphoma Research Consortium
3. Melanoma Research Consortium
4. DAVA Community Research Consortium

Accelerating Clinical Trials:

1. Site Diagnostics
2. Site Identification, Assessment, and Commitment
3. Medical Oncology Support
4. Accrual Workshop

 


Executive Leadership Team

Return to top

DAVA’s executive leadership is committed to improving patient care by realizing the full potential of Oncology drug development.

herve leger skirtMBT Walking Shoesmbt shoes clearanceghd mk4 stylernhl hockey jerseyscheap argentina world cup jerseys
dth="100%" border="0" cellspacing="0" cellpadding="10">

Vinay Jain, MD, FACP
CEO

vjain@davaonc.com
Office: 214.360.7477
Mobile: 214.207.8003

Mark Levonyak
President

mlevonyak@davaonc.com
Office: 214.360.7476
Mobile: 214.460.5051

Mike Reese, MD, FACP
VP of Clinical Trials Services

mreese@davaonc.com
Office: 214.360.7475
Mobile: 214.725.3300

John Eckardt , MD
Chief Medical Officer

jeckardt@davaonc.com
Office: 214.451.4520
Mobile: 314.614.5124

Annemieke DeMaggio, PhD
Scientific Director

ademaggio@davaonc.com
Office: 214.360.7479
Mobile: 972.310.3282

Nora Ku, MD
Medical Director, Research Consortia

nku@davaonc.com
Office: 214.451.4521
Mobile: 305.283.5896